Elongation factor 2 kinase (eEF‐2K) belongs to the atypical group of kinases and plays an important role in maintaining cellular homeostasis and tumor‐cell survival and proliferation,90 making eEF‐2K a potential target for cancer treatment, notably breast cancer. Here, EEF2K is linked to breast carcinoma.